 | |
| Clinical data | |
|---|---|
| MedlinePlus | a682237 |
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 21% |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.513 |
| Chemical and physical data | |
| Formula | C11H11NO2 |
| Molar mass | 189.214 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Phensuximide is an anticonvulsant in the succinimide class.
 | This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
Anticonvulsants are a diverse group of pharmacological agents used in the treatment of epileptic seizures. Anticonvulsants are also increasingly being used in the treatment of bipolar disorder and borderline personality disorder, since many seem to act as mood stabilizers, and for the treatment of neuropathic pain. Anticonvulsants suppress the excessive rapid firing of neurons during seizures. Anticonvulsants also prevent the spread of the seizure within the brain.
Succinimide is an organic compound with the formula (CH2)2(CO)2NH. This white solid is used in a variety of organic syntheses, as well as in some industrial silver plating processes. The compound is classified as a cyclic imide. It may be prepared by thermal decomposition of ammonium succinate.
Ethosuximide, sold under the brand name Zarontin among others, is a medication used to treat absence seizures. It may be used by itself or with other antiseizure medications such as valproic acid. Ethosuximide is taken by mouth.
